Back to Current Daily Care News Daily Care News from 2005

Daily Care News from 2005

    25 December 2005

  1. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes. See also Tight Glucose Control Cuts Heart Disease by Half in Type 1 Diabetes and Study: Good news for type 1 diabetics.
  2. Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor reports on the DexCom 3-day sensor. Free full text available in HTML and PDF formats and include photos of the sensor.
  3. Nocturnal differences in subcutaneous tissue glucose between forearm and abdominal sites during continuous glucose monitoring in normal subjects.
  4. The Effects of Aerobic Exercise on Glucose and Counterregulatory Hormone Concentrations in Children With Type 1 Diabetes.
  5. Postprandial Blood Glucose Is A Stronger Predictor Of Cardiovascular Events Than Fasting Blood Glucose In Type 2 Diabetes Mellitus, Particularly In Women. Lessons from the San Luigi Gonzaga Diabetes Study. Free full text available in PDF format.
  6. The Association of Increased Total Glycosylated Hemoglobin Levels with Delayed Age at Menarche in Young Women with Type 1 Diabetes. See also Onset of period delayed in young diabetic women.
  7. Knowledge about preconception care in French women with type 1 diabetes.
  8. Insulin detemir: a new basal insulin analogue.
  9. Subcutaneous insulin resistance successfully circumvented on long term by peritoneal insulin delivery from an implantable pump in four diabetic patients.
  10. Research Suggests Foods May Reduce CVD-linked Inflammation. See also Good Nutrition Evidence Proves Elusive.
  11. How should we treat type 2 diabetes in youth?
  12. Disparities in diabetes care: impact of mental illness.
  13. Impact of Active Versus Usual Algorithmic Titration of Basal Insulin and Point-of-Care Versus Laboratory Measurement of HbA1c on Glycemic Control in Patients With Type 2 Diabetes.
  14. Association Between Complementary and Alternative Medicine Use, Preventive Care Practices, and Use of Conventional Medical Services Among Adults With Diabetes.
  15. High Blood Sugar Hurts Thinking.

    18 December 2005

  16. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries.
  17. Efficacy of continuous glucose monitoring system to detect unrecognized hypoglycemia in children and adolescents with type 1 diabetes. Free full text available in Portuguese in HTML and PDF formats.
  18. Willingness to pay for inhaled insulin: a contingent valuation approach.
  19. Classification of diabetes in young adults: New concepts for an old disease.
  20. Do HbA(1)c levels and the self-monitoring of blood glucose levels adequately reflect glycaemic control during pregnancy in women with type 1 diabetes mellitus?
  21. Audit of the outcome of pregnancy in diabetic women in Soweto, South Africa, 1992 - 2002.

    11 December 2005

  22. Effect of Prior Hyperglycemia on IL-6 Responses to Exercise in Children with Type 1 Diabetes.
  23. Efficacy and safety of a mixture of two different brands of insulin products in patients with type 1 diabetes mellitus.
  24. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.
  25. A practical insulin infusion algorithm for the establishment of euglycaemia in both lean and obese patients with type 1 and type 2 diabetes.
  26. Can diabetes management programs create sustained improvements in disease outcomes?
  27. Behavioral assessment and intervention in pediatric diabetes. Free full text available in PDF format.
  28. Health care discrimination, processes of care, and diabetes patients' health status.
  29. One-year follow-up effects of diabetes rehabilitation for patients with prolonged self-management difficulties.
  30. Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome.
  31. Economic costs associated to type 1 diabetes.

    4 December 2005

  32. Efficacy and Safety of Insulin Glulisine in Patients with Type 1 Diabetes.
  33. Impact of insulin antibodies on insulin aspart pharmacokinetics and pharmacodynamics after 12-week treatment with multiple daily injections of biphasic insulin aspart 30 in patients with type 1 diabetes.
  34. Administration of Lispro Insulin with Meals Improves Glycemic Control, Increases Circulating Leptin, and Suppresses Ghrelin Compared with Regular/NPH Insulin in Female Patients with Type-1 Diabetes. Free full text available in PDF format.
  35. Persistent effects of a pedagogical device targeted at prevention of severe hypoglycaemia: a randomized, controlled study.
  36. Insulin Pump Therapy and Health-Related Quality of Life in Children and Adolescents with Type 1 Diabetes.
  37. Normal physical working capacity in prepubertal children with type 1 diabetes compared with healthy controls.
  38. The effects of multisystemic therapy on diabetes stress among adolescents with chronically poorly controlled type 1 diabetes: findings from a randomized, controlled trial.
  39. Gender Differences in Adherence and Metabolic Control in Urban Youth with Poorly Controlled Type 1 Diabetes: The Mediating Role of Mental Health Symptoms.
  40. Cardiovascular benefits of simultaneous pancreas-kidney transplant versus kidney alone transplant in diabetic patients.
  41. Use of technology to track program outcomes in a diabetes self-management program.

    20 November 2005

  42. Smoking and incidence of diabetes among U.S. adults: findings from the Insulin Resistance Atherosclerosis Study. See also the discussion at BioCritique.
  43. The First Diabetes Educator Is the Family: Using Illness Representation to Recognize a Multigenerational Legacy of Diabetes.

    13 November 2005

  44. Educating families from ethnic minorities in type 1 diabetes-experiences from a Danish intervention study.
  45. Nationwide cross-sectional survey of 3560 children and adolescents with diabetes in Italy.
  46. Early changes in 24-hour ambulatory blood pressure are associated with high normal albumin excretion rate in children with type 1 diabetes mellitus.
  47. Hypoglycemia, hypoglycemia unawareness and counterregulation in children and adolescents with type 1 diabetes mellitus.

    6 November 2005

  48. Brief report: in-home family therapy for adolescents with poorly controlled diabetes: failure to maintain benefits at 6-month follow-up.
  49. Multisystemic Treatment of Poorly Controlled Type 1 Diabetes: Effects on Medical Resource Utilization.
  50. A real-time, mobile phone-based telemedicine system to support young adults with type 1 diabetes.
  51. Parents' perceptions of factors that affect successful diabetes management for their children.
  52. Implementing a new diabetes resource for Wisconsin schools and families.
  53. Blood Glucose Awareness Training (BGAT-2): Long-term benefits. Free full text available in HTML and PDF formats.
  54. Oral Hygiene in Children with Type I Diabetes Mellitus.
  55. Dietary and Oral Hygiene Habits in Children with Type I Diabetes Mellitus Related to Dental Caries.
  56. The patient with diabetes mellitus: etiology, epidemiology, principles of medical management, oral disease burden, and principles of dental management.
  57. No need for glycosuria/proteinuria screen in pregnant women.

    30 October 2005

  58. Accuracy of Newer-Generation Home Blood Glucose Meters in a Diabetes Research in Children Network (DirecNet) Inpatient Exercise Study.
  59. Factors associated with glycaemic outcome of childhood diabetes care in Denmark.
  60. The relationship between parental perceptions of diabetes and glycaemic control.
  61. Continuous subcutaneous insulin infusion is sometimes a good choice in case of poorly regulated diabetes mellitus type I.
  62. The insulin pump: why not use it for every type I diabetic patient?
  63. Validation of the Continuous Glucose Monitoring System (CGMS) by the Use of Two CGMS Simultaneously in Pregnant Women with Type 1 Diabetes Mellitus.
  64. Is pregnancy a risk factor for microvascular complications? The EURODIAB Prospective Complications Study.
  65. A Randomized Controlled Trial of the Effect of Real-Time Telemedicine Support on Glycemic Control in Young Adults With Type 1 Diabetes (ISRCTN 46889446).
  66. Evaluation of a programme of group visits and computer-assisted consultations in the treatment of adolescents with Type 1 diabetes.
  67. Short-term effects of cognitive behavioural group training (CBGT) in adult Type 1 diabetes patients in prolonged poor glycaemic control. A randomized controlled trial.
  68. Urinary albumin levels in the normal range determine arterial wall thickness in adults with Type 2 diabetes: a FIELD substudy.
  69. Management of children and adolescents with diabetes mellitus: personal experience.
  70. Diabetes Website Review: See also the AIDA web site.
  71. Resistance to Insulin Therapy Among Patients and Providers: Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study reports on the reluctance of health care providers to prescribe insulin to adults with type 2 diabetes.

    23 October 2005

  72. Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus.
  73. Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.
  74. Brain glucose concentrations in healthy humans subjected to recurrent hypoglycemia.
  75. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus.
  76. Continuous glucose monitoring in diabetic long distance runners.
  77. Diabetes, aging, and cognitive decline.

    16 October 2005

  78. Treatment of young type 1 diabetes patients in an adult diabetes clinic.
  79. The pre-school child with diabetes: a cross-cultural survey of dietary habits and parental attitudes.
  80. Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness.
  81. Continuous glucose monitoring system: an attractive support tool in diabetes education.
  82. The practical management of patients with type 1 diabetes requiring in-patient care due to an eating disorder.
  83. Randomized Controlled Clinical Trial of Blood Glucose Awareness Training (BGAT III) in Switzerland and Germany.
  84. How do people with diabetes access information?
  85. Strokes and diabetes.
  86. Polycystic ovarian syndrome and diabetes.

    9 October 2005

  87. Influence of caregiver stress and coping on glycemic control of young children with diabetes.
  88. Health-related quality of life and metabolic control in adolescents with diabetes: the role of parental care, control, and involvement.
  89. The Association of Increased Total Glycosylated Hemoglobin Levels with Delayed Age at Menarche in Young Women with Type 1 Diabetes. Free full text available in PDF format.
  90. The role of work-related and personal factors in diabetes self-management.

    1 October 2005

  91. Evaluating the Clinical Accuracy of Two Continuous Glucose Sensors Using Continuous Glucose–Error Grid Analysis.
  92. Glycemic Characteristics in Continuously Monitored Patients With Type 1 and Type 2 Diabetes: Normative values.
  93. Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia.
  94. Early hypoglycaemia after accidental intramuscular injection of insulin glargine.
  95. Frequency and Timing of Severe Hypoglycemia Affects Spatial Memory in Children With Type 1 Diabetes.
  96. Decreased isometric muscle strength after acute hyperglycaemia in Type 1 diabetic patients.
  97. Prandial hyperglycemia: is it important to track and treat?
  98. Dose Response of Inhaled Dry-Powder Insulin and Dose Equivalence to Subcutaneous Insulin Lispro.
  99. Mortality in Childhood-Onset Type 1 Diabetes: A population-based study.
  100. A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes.
  101. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study.
  102. Diabetic Peripheral Neuropathy and Depressive Symptoms.
  103. A computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation.
  104. Healer shopping in Africa: new evidence from rural-urban qualitative study of Ghanaian diabetes experiences explores the challenge of providing diabetes care in poor countries. Free full text available in HTML and PDF formats.

    25 September 2005

  105. Diabetes mellitus type 1 in five military aviators: flying with insulin.
  106. Contrasting Challenges of Insulin Pump Therapy in a Toddler and Adolescent With Type 1 Diabetes.
  107. Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus.
  108. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
  109. Concomitant Use of Insulin Glargine and NPH in Type I Diabetes.
  110. Will Long Acting Insulin Analogs Influence the Use of Insulin Pump Therapy in Type 1 Diabetes?
  111. Identification of factors associated with impaired hypoglycaemia awareness in patients with type 1 and type 2 diabetes mellitus.
  112. Correlation of same-visit HbA1c test with laboratory-based measurements: A MetroNet study. Free full text available in HTML and PDF formats.
  113. Disordered Eating Behaviors in Youth With Type 1 Diabetes.
  114. Effects of sprint training on extrarenal potassium regulation with intense exercise in type 1 diabetes.
  115. Invasiveness as a Barrier to Self-Monitoring of Blood Glucose in Diabetes.
  116. Force Requirements and Insulin Delivery Profiles of Four Injection Devices.
  117. Assessment of Dose Selection Attributes with Audible Notification in Insulin Pen Devices.
  118. Alternative site self blood glucose testing is preferred by women with gestational diabetes.
  119. Cerebral edema during treatment of diabetic ketoacidosis in an adult with new onset diabetes.
  120. Gastric electrical stimulation: an alternative surgical therapy for patients with gastroparesis See also Alternative Treatment for Gastroparesis.
  121. GPs' perspectives of type 2 diabetes patients' adherence to treatment: A qualitative analysis of barriers and solutions. Free full text available in HTML and PDF formats.
  122. Hi-tech advancements in diabetes management from Nephrology News & Issues Online examines the Guardian RT and using oral medications in kids with diabetes.

    18 September 2005

  123. Inhaled insulin for diabetes mellitus. Free full text available in HTML and PDF formats.
  124. Therapy with insulin glargine (Lantus®) in toddlers, children and adolescents with type 1 diabetes.
  125. Continuous Glucose Monitoring Has Potential for Patients With Diabetes.
  126. Exenatide Achieves Glycemic Control Equivalent to Glargine.
  127. Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes.
  128. Explicit memory performance in infants of diabetic mothers at 1 year of age.
  129. Depression and diabetes in children and adolescents.
  130. Brief Report: Glycemic Control, Quality of Life, and School Experiences Among Students with Diabetes.
  131. Family Dynamics and Chronic Illness: Children with Diabetes in the Context of their Families.
  132. Canine diabetes mellitus: can old dogs teach us new tricks?

    11 September 2005

  133. Variability among five over-the-counter blood glucose monitors.
  134. Diabetes not associated with depression.
  135. Neonatal diabetes mellitus: Insulin pump as an alternative management strategy.
  136. The case for low carbohydrate diets in diabetes. Free full text available in HTML and PDF formats.
  137. Association between alcohol consumption and diabetes preventive practices. Free full text available in PDF format.
  138. Aspirin prophylaxis in diabetes mellitus.
  139. Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes.
  140. Controversies in the medical clearance of recreational scuba divers: updates on asthma, diabetes mellitus, coronary artery disease, and patent foramen ovale.

    4 September 2005

  141. Exercise and newer insulins: how much glucose supplement to avoid hypoglycemia? See also Glucose Supplement May Be Needed Before Exercise in Type 1 Diabetes.
  142. Understanding health by adolescents with diabetes mellitus type 1 assessed by own criteria.
  143. Depression and the adolescent with type 1 diabetes: the covert comorbidity.
  144. Understanding emotional and psychological considerations of children with diabetes: tips for school nurses.
  145. Chronic health conditions and student performance at school.
  146. LEAP (Lantus Early Access Programme) in Sarajevo.
  147. PHARMAC and long-acting insulin analogues: a poor man's insulin pump--but not available to the poor man.
  148. Approved IFCC Recommendation on Reporting Results for Blood Glucose (Abbreviated).
  149. Stress Hurts Teen Diabetics.
  150. Incretin mimetics: promising new therapeutic options in the treatment of type 2 diabetes.
  151. Implementing tight glucose control after coronary artery bypass surgery.

    28 August 2005

  152. Diabetes Management in Adolescents in Poor Metabolic Control.
  153. Pediatric Parenting Stress Among Parents of Children with Type 1 Diabetes: The Role of Self-Efficacy, Responsibility, and Fear.
  154. Pharmacokinetics, Prandial Glucose Control, and Safety of Insulin Glulisine in Children and Adolescents With Type 1 Diabetes.
  155. Influence of Glycemic Index/Load on Glycemic Response, Appetite, and Food Intake in Healthy Humans.
  156. Effects of an ad libitum low-glycemic load diet on cardiovascular disease risk factors in obese young adults. Free full text available in HTML and PDF formats. See also Low–Glycemic-Load Diet Lowers CV Risk.
  157. Eating disorders in patients with type 1 diabetes: a meta-analysis. See also Bulimia Nervosa Risk Elevated In Patients With Type 1 Diabetes.
  158. The Impact of Psychiatric Comorbidities on Readmissions for Diabetes in Youth.
  159. Clinical Inertia Contributes to Poor Diabetes Control in a Primary Care Setting.
  160. Great Strides in Therapy Fail to Reach All in Need.
  161. Type 2 diabetes and pregnancy.
  162. FDA reviews of new drugs may signal tougher scrutiny.

    21 August 2005

  163. Use of insulin glargine in children under age 6 with type 1 diabetes.
  164. Aerobic exercise capacity in normal adolescents and those with type 1 diabetes mellitus.
  165. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.
  166. Case study: contrasting challenges of insulin pump therapy in a toddler and adolescent with type 1 diabetes.
  167. Disordered eating behaviors in youth with type 1 diabetes.
  168. Accuracy, utility and complications of continuous glucose monitoring system (CGMS) in pediatric patients with type 1 diabetes. Also available in PDF format.
  169. Adult-like but regressive increase of intima-media thickness and roughness in a child with type 1 diabetes.
  170. Health Insurance and Diabetes: The Lack of Available, Affordable, and Adequate Coverage.
  171. Contributions of Basal and Post-Prandial Hyperglycaemia to Micro- and Macrovascular Complications in People With Type 2 Diabetes.
  172. The impact of diabetes on patient outcomes after ankle fracture. See also Nationwide Duke study examines surgical diabetes complications.
  173. Hyperglycemic hyperosmolar non-ketotic syndrome in children with type 2 diabetes.
  174. Efficacy and safety of hypoglycemic drugs in children with type 2 diabetes mellitus. See also Oral Meds Good for Controlling Type II Diabetes in Children.
  175. Second-Generation Antipsychotics and the Risk of Insulin Resistance, Dyslipidemia in Children.

    14 August 2005

  176. Usefulness of the addition of metformin to insulin in pediatric patients with type 1 diabetes mellitus.
  177. Switch to Multiple Daily Injections With Insulin Glargine and Insulin Lispro From Continuous Subcutaneous Insulin Infusion With Insulin Lispro: A Randomized, Open-Label Study Using a Continuous Glucose Monitoring System.
  178. Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes.
  179. A 3-year prospective randomized controlled clinical trial of group care in type 1 diabetes.
  180. American College of Endocrinology and American Association of Clinical Endocrinologists Position Statement on Patient Safety and Medical System Errors in Diabetes and Endocrinology.
  181. Characteristics Associated with Neuropathy and/or Retinopathy in a Hospital Outpatient Diabetic Clinic.

    7 August 2005

  182. Subcutaneous Insulin Lispro May Be Cost-Effective for Diabetic Ketoacidosis.
  183. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study.

    31 July 2005

  184. Subcutaneous Use of a Fast-Acting Insulin Analog: An alternative treatment for pediatric patients with diabetic ketoacidosis.
  185. Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors.
  186. The effect of pramlintide on hormonal, metabolic or symptomatic responses to insulin-induced hypoglycaemia in patients with type 1 diabetes.
  187. Effect of soy protein-rich diet on renal function in young adults with insulin-dependent diabetes mellitus.
  188. Acute Psychological Stress Affects Glucose Concentrations in Patients With Type 1 Diabetes Following Food Intake but not in the Fasting State.
  189. Oral Contraceptives, Angiotensin-Dependent Renal Vasoconstriction, and Risk of Diabetic Nephropathy.
  190. Depressive Symptoms in Mothers of Infants Identified as Genetically at Risk for Type 1 Diabetes.
  191. Depression and Diabetes.
  192. Transfer of Glyburide and Glipizide Into Breast Milk.
  193. Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus.
  194. Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmology.
  195. Patterns of care as a risk factor for the development of vision-threatening diabetic retinopathy: a population-based matched case-control study using insurance claims (Medicare) data.
  196. Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients.
  197. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects.
  198. Impact of an Electronic Medical Record on Diabetes Quality of Care. Free full text available in HTML and PDF formats. See also Use of Electronic Medical Record Has Little Impact on Improved Diabetes Quality of Care.
  199. New Blood Test Could Ease Life for Patients with Rare form of Diabetes.

    24 July 2005

  200. Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus.
  201. Rate of hypoglycaemia and insulin dosage in children during the initial therapy of type 1 diabetes mellitus.
  202. Alcohol may increase delayed low blood sugar risk. See extract at Day After the Night Before: Influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes.
  203. Diabetes groups worry about looming lack of insulin options.
  204. The frequency of mild and severe fetal malformations in diabetic pregnant women with high values of glycosilated hemoglobin in early pregnancy.
  205. An evaluation of the change in activity and workload arising from diabetic ophthalmology referrals following the introduction of a community based digital retinal photographic screening programme.
  206. Microcirculation of the diabetic foot.
  207. Microalbuminuria and Abnormal Ambulatory Blood Pressure in Adolescents With Type 2 Diabetes Mellitus.
  208. Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis. See also Cholesterol Drugs May Harm Ill Diabetics.

    17 July 2005

  209. A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes.
  210. Diabetes and progression of coronary calcium under the influence of statin therapy.
  211. Brief Report: Disordered Eating and Psychosocial Factors in Adolescent Females with Type 1 Diabetes Mellitus.
  212. Diabetic ketoacidosis in children.
  213. Sibling birthweight as a predictor of macrosomia in women with type 1 diabetes.
  214. A comparison of blood glucose meters in Australia.
  215. Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients.
  216. Separate functional features of proinsulin C-peptide.

    10 July 2005

  217. Lilly To Discontinue Four Insulin Products. See also Eli Lilly will end its sale of 4 insulins.
  218. Screening for Retinopathy in the Pediatric Patient With Type 1 Diabetes Mellitus. Also available in PDF format.
  219. Identification of urinary protein pattern in Type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.

    3 July 2005

  220. Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children. A comparison with conventional insulin therapy.
  221. The Effect of Rosiglitazone on Overweight Subjects With Type 1 Diabetes.
  222. Use of Multisystemic Therapy to Improve Regimen Adherence Among Adolescents With Type 1 Diabetes in Chronic Poor Metabolic Control.
  223. Web-Based Care Management in Patients With Poorly Controlled Diabetes.

    26 June 2005

  224. Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service.
  225. Comparison of three multiple injection regimens for Type 1 diabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin.
  226. Reproducibility and reliability of hypoglycaemic episodes recorded with Continuous Glucose Monitoring System (CGMS) in daily life.
  227. Physical activity and energy intake in adolescent girls with Type 1 diabetes.
  228. Increased incidence and severity of diabetic ketoacidosis among uninsured children with newly diagnosed type 1 diabetes mellitus.
  229. Clinical presentation of type 1 diabetes.
  230. Characteristics of childhood and adult-onset type 1 diabetes in a multi-ethnic population.
  231. Predictors of glucose control in children and adolescents with type 1 diabetes mellitus.
  232. Treatment regimen determines the relationship between depression and glycemic control.
  233. Response shift and glycemic control in children with diabetes. Free full text available in PDF format.
  234. Disease management in the young diabetic patient: glucose monitoring, coping skills, and treatment strategies.
  235. Home blood glucose prediction: validation, safety, and efficacy testing in clinical diabetes.
  236. Home blood glucose prediction: clinical feasibility and validation in islet cell transplantation candidates.
  237. Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?
  238. Screening for Abnormalities of Carbohydrate Metabolism in Teens. Also available in PDF format.
  239. Effect of nebulized albuterol on blood glucose in patients with diabetes mellitus with and without cystic fibrosis.
  240. Visual Outcomes of Pan-retinal Photocoagulation in Diabetic Retinopathy at One-year Follow-up and Associated Risk Factors. Free full text available in HTML format.

    19 June 2005

  241. Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy.
  242. Effect of keto-acidosis on seizure occurrence in diabetic patients.
  243. Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes.
  244. Life versus disease in difficult diabetes care: conflicting perspectives disempower patients and professionals in problem solving.

    12 June 2005

  245. Patterns of physical activity determined by heart rate monitoring among diabetic children.
  246. Blood glucose awareness training helps return insulin-treated aviators to the cockpit.
  247. Diabetes-Related Hypoglycemia Risk Greater With Jogging Than With Team Sports.

    5 June 2005

  248. Prevalence of diabetes complications 6 years after diagnosis in an incident cohort of childhood diabetes.
  249. Pregnancy in type 1 diabetes: insulin pump versus intensified conventional therapy.
  250. Risk of specific congenital abnormalities in offspring of women with diabetes.
  251. Response to nocturnal alarms using a real-time glucose sensor.
  252. Diabetes in children and adolescents from ethnic minorities: barriers to education, treatment and good metabolic control.
  253. Glycemic Control and Treatments in Type 1 Diabetes in childhood and adolescence in Portugal.
  254. Insulin therapy: current alternatives.
  255. Caffeine Benefits People With Type 1 Diabetes.
  256. Slowing Progression Along the Renal Disease Continuum. Free full text available in HTML and PDF formats.
  257. Economic burden on families of childhood type 1 diabetes in urban Sudan.

    29 May 2005

  258. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy.
  259. A Randomized Controlled Trial of Insulin Pump Therapy in Young Children With Type 1 Diabetes.
  260. Influence of an Early-Onset Age of Type 1 Diabetes on Cerebral Structure and Cognitive Function.
  261. Influence of Caffeine on Frequency of Hypoglycemia Detected by Continuous Interstitial Glucose Monitoring System in Patients With Long-Standing Type 1 Diabetes.
  262. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.
  263. Dietary Glycemic Index, Glycemic Load, Fiber, Simple Sugars, and Insulin Resistance.
  264. Research Shows Benefit of Low–Glycemic-Load Diet Over Low-Fat Diet.
  265. The Decline in Blood Glucose Levels Is Less With Intermittent High-Intensity Compared With Moderate Exercise in Individuals With Type 1 Diabetes.
  266. Management of Competitive Athletes With Diabetes.
  267. Make Your Diabetic Patients Walk: Long-term impact of different amounts of physical activity on type 2 diabetes. Free full text available in HTML and PDF formats.
  268. Needlestick injury in acute care nurses caring for patients with diabetes mellitus: a retrospective study.
  269. Wellness Goes Wireless; New multipurpose cell phones, PDAs help patients monitor and report vital signs.

    22 May 2005

  270. Cardiovascular effects of type 1 diabetes mellitus in children.
  271. Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in longstanding type 1 diabetes..
  272. Substance abuse in young patients with type 1 diabetes: easily neglected in complex medical management.

    15 May 2005

  273. Optimized Basal-bolus Insulin Regimens In Type 1 Diabetes: Insulin Glulisine Versus Regular Human Insulin In Combination With Basal Insulin Glargine.
  274. Adjunctive Therapy with Pramlintide Lowers HbA1c without Concomitant Weight Gain and Increased Risk of Severe Hypoglycemia in Patients with Type 1 Diabetes Approaching Glycemic Targets.
  275. Detection of Cerebral {beta}-Hydroxy Butyrate, Acetoacetate, and Lactate on Proton MR Spectroscopy in Children with Diabetic Ketoacidosis.
  276. Diabetic ketoacidosis.
  277. The Dawn Phenomenon Revisited: Implications For Diabetes Therapy.
  278. Reliability of reporting of self-monitoring of blood glucose in pregnant women.
  279. Contribution of hypoglycemia to medical care expenditures and short-term disability in employees with diabetes.
  280. Psychological factors associated to patient's treatment compliance in Chilean diabetic teenagers. Free full text available in Spanish.
  281. Superior segmental optic nerve hypoplasia and diabetes mellitus.
  282. Intensified insulin therapy of type 2 diabetes mellitus: Pre- or postprandial injection of aspart insulin?
  283. Hyperosmolar Hyperglycemic Crisis: An Acute Life-threatening Event In Children And Adolescents With Type 2 Diabetes Mellitus.

    8 May 2005

  284. Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus.
  285. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis.
  286. Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus.
  287. Effect of Intensive Glycemic Control on Levels of Markers of Inflammation in Type 1 Diabetes Mellitus in the Diabetes Control and Complications Trial.
  288. Pendra goes Dutch: lessons for the CE mark in Europe.
  289. Optimal use of quick-acting insulin analogue in combination with basal insulin and its long-term effect in Japanese children and adolescents with type 1 diabetes.
  290. Age, metabolic control and type of insulin regime influences health-related quality of life in children and adolescents with type 1 diabetes mellitus.
  291. Long-term interactive group education for type 1 diabetic patients.
  292. Association of sleep time with diabetes mellitus and impaired glucose tolerance.
  293. Internet program launched to prevent blindness in diabetic patients.

    1 May 2005

  294. Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system.
  295. Memory of insulin pumps and their record as a source of information about insulin therapy in children and adolescents with type 1 diabetes.
  296. A novel approach to continuous glucose analysis utilizing glycemic variation.
  297. Impact of modem-transferred blood glucose data on clinician work efficiency and patient glycemic control.
  298. Surveillance and Treatment for CVD in Children With Diabetes.
  299. ACE Inhibitor Prevents Early Sign of Kidney Disease.
  300. Statins and diabetes.
  301. FDA Approves New Adjunct Treatment for Glucose Control .
  302. A Randomized Multicenter Trial Comparing the GlucoWatch Biographer With Standard Glucose Monitoring in Children With Type 1 Diabetes.
  303. A Double-Blind, Randomized, Dose-Response Study Investigating the Pharmacodynamic and Pharmacokinetic Properties of the Long-Acting Insulin Analog Detemir.
  304. Awareness and Treatment of Dyslipidemia in Young Adults With Type 1 Diabetes.
  305. Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes.
  306. Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea.
  307. Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes.
  308. Diabetes care provision and glycaemic control in Northern Ireland: a UK regional audit.
  309. Elevated Pregnancy Losses at High and Low Extremes of Maternal Glucose in Early Normal and Diabetic Pregnancy.
  310. Pregnancy Experience Among Women With and Without Gestational Diabetes in the U.S., 1995 National Survey of Family Growth.
  311. Eliminating Inpatient Sliding-Scale Insulin: A reeducation project with medical house staff.

    24 April 2005

  312. Research reveals emotional trauma parents face when a child is diagnosed with diabetes discusses Newly diagnosed childhood diabetes: a psychosocial transition for parents?
  313. Childhood diabetes presenting with hyperosmolar dehydration but without ketoacidosis: a report of three cases.
  314. Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS).
  315. Predictors of first stroke in Type 1 diabetes: The Fremantle Diabetes Study.
  316. Lifetime risk of symptomatic carpal tunnel syndrome in Type 1 diabetes.
  317. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin.

    17 April 2005

  318. Lipoprotein composition in children and adolescents with type 1 diabetes mellitus.
  319. Rates of diabetes mellitus-related complications in a contemporary adolescent cohort.
  320. Restless legs syndrome and sleep problems in children and adolescents with insulin-dependent diabetes mellitus type 1.
  321. Education and telephone case management for children with type 1 diabetes: a randomized controlled trial.
  322. Childhood precursors of adolescent outcomes in type 1 diabetes mellitus.
  323. Pediatric aspects of diabetic kidney disease.
  324. Screening for kidney disease in adults with diabetes and prediabetes.
  325. Differences in corneal thickness and corneal endothelium related to duration in Diabetes.
  326. Properties of pramlintide and insulin upon mixing. Free full text available in HTML and PDF formats.
  327. Online diabetes education: design and evaluation with prospective diabetes camp counsellors.

    10 April 2005

  328. Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool?
  329. Vitiligo Associated With Subcutaneous Insulin Lispro Infusion in Type 1 Diabetes. Also available in PDF format (see page 4).
  330. Frequency and perceived burden of diabetes self-management activities in employees with insulin-treated diabetes: relationships with health outcomes.
  331. Hemolytic Anemia Manifesting As Improved A1C Values.
  332. Newly diagnosed childhood diabetes: a psychosocial transition for parents?
  333. Problems That Extend Visit Time and Cost in Diabetes Care: 1. How Depression May Affect the Efficacy and Cost of Care of Diabetic Patients. Also available in PDF format.
  334. Glucagon-Like Peptide 1-Based Therapies for Type 2 Diabetes: A Focus on Exenatide . Also available in PDF format.
  335. A Real-World Approach to Insulin Therapy in Primary Care Practice. Also available in PDF format.
  336. A Systematic Review of Diabetes Disease Management Programs. Also available in PDF format.
  337. Proactive Case Management of High-risk Patients With Type 2 Diabetes Mellitus by a Clinical Pharmacist: A Randomized Controlled Trial. Also available in PDF format.
  338. Oral Agents for Type 2 Diabetes: An Update. Also available in PDF format.
  339. Health Outcomes of a 58-Year-Old Man With Type 2 Diabetes Who Had Roux-en-Y Gastric Bypass. Also available in PDF format.

    3 April 2005

  340. Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine.
  341. School attendance in children with Type 1 diabetes.
  342. Scuba diving with diabetes mellitus--the UK experience 1991-2001.
  343. Adherence to physical activity in young people with type 1 diabetes.
  344. Factors related to CSII compliance.
  345. What could be the reasons for giving up the implanted pump treatment?
  346. Motor vehicle accidents during episodes of hypoglycaemia--case reports and lessons to be learnt.
  347. Effect of a levonorgestrel intrauterine system on women with type 1 diabetes: a randomized trial.
  348. Is the relationship between adherence behaviours and glycaemic control bi-directional at adolescence? A longitudinal cohort study..
  349. Patient adherence improves glycemic control.
  350. Barriers to A1C Testing Among a Managed Care Population.
  351. Implementing the chronic care model for improvements in diabetes care and education in a rural primary care practice.
  352. The spoken knowledge in low literacy in diabetes scale: a diabetes knowledge scale for vulnerable patients.
  353. IT'S MINE: Initiating Treatment Success--My Individualized Nutrition and Exercise Plan.
  354. Cross-sectional study of care, socio-economic status and complications in young French patients with type 1 diabetes mellitus.
  355. Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy.
  356. New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis.
  357. Workplace exposures and employment patterns in adult onset asthmatics and diabetics.
  358. Mood and Cognitive Function in Elderly Diabetic Patients Living in Care Facilities.
  359. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes.

    27 March 2005

  360. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective.
  361. Insulin pump use in young adolescents with type 1 diabetes: a descriptive study.
  362. Reduced Hypoglycemia Risk With Insulin Glargine: A meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.
  363. Self-monitoring of blood glucose in children and teens with diabetes.
  364. Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study.
  365. The Role of Amylin and Glucagon in the Dampening of Glycemic Excursions in Children With Type 1 Diabetes.
  366. Leisure Time Physical Activity Is Associated With Poor Glycemic Control in Type 1 Diabetic Women.
  367. A randomized trial of regular standardized telephone contact by a diabetes nurse educator in adolescents with poor diabetes control.
  368. Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity.
  369. Twenty years of a multidisciplinary paediatric diabetes home care unit.
  370. Effect of bread containing resistant starch on postprandial blood glucose levels in humans.
  371. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. See also Cocoa, diabetes, and hypertension: should we eat more chocolate? and Dark Chocolate May Improve Insulin Sensitivity/Resistance and Blood Pressure.

    20 March 2005

  372. Self-Care Autonomy and Outcomes of Intensive Therapy or Usual Care in Youth with Type 1 Diabetes.
  373. Sharing stories: complex intervention for diabetes education in minority ethnic groups who do not speak English. Free full text available in HTML and PDF formats.
  374. Going high with type 1 diabetes.
  375. Personality factors and disordered eating in young women with type 1 diabetes mellitus.
  376. Identity and adherence in a diabetes patient: transformations in psychotherapy.
  377. The Association between Health Insurance Coverage and Diabetes Care; Data from the 2000 Behavioral Risk Factor Surveillance System.
  378. Employees with diabetes are not automatically more tired.

    13 March 2005

  379. What is hypoglycemia in patients with well-controlled type 1 diabetes treated by subcutaneous insulin pump with use of the continuous glucose monitoring system?
  380. Abnormal myocardial perfusion and contractile recruitment during exercise in type 1 diabetic patients.
  381. Prandial glucose regulation in the glucose triad: emerging evidence and insights.
  382. Comparison of pre-dinner regular versus pre-lunch NPH as a third insulin application in adolescents with type 1 diabetes from a Public Health Service. Free full text available in Portuguese.
  383. Health insurance for type 1 diabetes mellitus: US competition and French coverage.
  384. Body adiposity and its influence on clinical and metabolic parameters of patients with type 1 diabetes. Free full text available in Portuguese.
  385. Diabetic pregnancy: outpatient follow-up in a Brazilian University Hospital. Free full text available in Portuguese.

    6 March 2005

  386. Accuracy of the Modified Continuous Glucose Monitoring (CGMS((R))) Sensor in an Outpatient Setting: Results from a Diabetes Research in Children Network (DirecNet) Study.
  387. Home use of the GlucoWatch G2 biographer in children with diabetes.
  388. EEG abnormalities with and without relation to severe hypoglycaemia in adolescents with type 1 diabetes.
  389. Depression in diabetic patients; The relationship between mood and glycemic control.
  390. Subjective well-being before and after the onset of diabetes mellitus Results of the Nord-Trondelag Health Study.
  391. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea.

    27 February 2005

  392. Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII.
  393. Effects of Exercise on the Absorption of Insulin Glargine in Patients With Type 1 Diabetes.
  394. The Effects of Type 1 Diabetes on Cognitive Performance.
  395. The Case for Biennial Retinopathy Screening in Children and Adolescents.
  396. Insulin pump therapy, should we consider it more often?
  397. Caries risk assessment as a predictor of metabolic control in young Type 1 diabetics.
  398. The J-shape effect of alcohol intake on the risk of developing acute coronary syndromes in diabetic subjects: the CARDIO2000 II Study.
  399. Impact of Early Neonatal Breast-Feeding on Psychomotor and Neuropsychological Development in Children of Diabetic Mothers.
  400. Early Growth in Offspring of Diabetic Mothers.
  401. Increasing Prevalence of Gestational Diabetes Mellitus (GDM) Over Time and by Birth Cohort.
  402. FDA Approves Drugs for Peripheral Neuropathy.
  403. New Polymeal Diet Cuts Risk For Heart Disease By 76%
  404. Caffeine Ingestion Is Associated With Reductions in Glucose Uptake Independent of Obesity and Type 2 Diabetes Before and After Exercise Training.
  405. Crusaders for the Cause.
  406. Cognitive behavioural group training (CBGT) for patients with type 1 diabetes in persistent poor glycaemic control: who do we reach?
  407. Diabetic Nephropathy: Diagnosis, Prevention, and Treatment.

    20 February 2005

  408. Severe hypoglycaemia, metabolic control and diabetes management in children with type 1 diabetes in the decade after the Diabetes Control and Complications Trial - a large-scale multicentre study.
  409. Past 10-year status of insulin therapy for preschool-age Japanese children with type 1 diabetes.
  410. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
  411. Self-care in diabetes: model of factors affecting self-care.
  412. Consequences of alcohol use in diabetics.

    13 February 2005

  413. Reversible cognitive deterioration after a single episode of severe hypoglycaemia: a case report is the full text report of a study previously referenced in abstract form.
  414. Evaluation of a self-awareness education session for youth education with type 1 diabetes.
  415. Treatment of the patient with diabetes: importance of maintaining target HbA(1c) levels..
  416. Diabetes and pregnancy; the prevention of hypoglycaemia.
  417. Type 2 Diabetes Mellitus in the pediatric age group. Free full text available.
  418. Glycosylated haemoglobin levels and the severity of erectile function in diabetic men.

    6 February 2005

  419. Arterial compliance changes in diabetic normotensive patients after angiotensin-converting enzyme inhibition therapy.
  420. Fear and other disturbances of severe hypoglycaemia in children and adolescents with type 1 diabetes mellitus.
  421. Children's Appraisals of Maternal Involvement in Coping With Diabetes: Enhancing Our Understanding of Adherence, Metabolic Control, and Quality of Life Across Adolescence.
  422. Eating disorders and eating problems among adolescents with type 1 diabetes: exploring relationships with temperament and character.
  423. Spotlight on insulin detemir in type 1 and 2 diabetes mellitus.

    30 January 2005

  424. Lilly Discontinues 1.5ml Humalog Cartridges.
  425. Diabetes UK Reports Possible fault in OptiPen Pro-1.
  426. Improved diabetes control by using 'close adjustment algorithms'.
  427. Episodes of severe hypoglycemia--increasing problem in type 1 diabetes.
  428. Hypoglycemia Anticipation, Awareness and Treatment Training (HAATT) Reduces Occurrence of Severe Hypoglycemia Among Adults with Type 1 Diabetes Mellitus.
  429. Early Diabetes-Related Complications in Adolescents.
  430. Pregnancy In Adolescents With Type 1 Diabetes.
  431. The role of glycemic control and incidence of spontaneous abortions pregnant women with type 1 diabetes mellitus.
  432. T-cell receptor repertoire and function in umbilical cord blood lymphocytes from newborns of type 1 diabetic mothers.
  433. Pubertal stage and hypoglycaemia counterregulation in type 1 diabetes.
  434. Insulin Glulisine: Insulin Receptor Signaling Characteristics In Vivo.
  435. Preventing Childhood Obesity: Schools and communities need to do their part to encourage healthy habits.
  436. Addition of Primary Care–Based Retinal Imaging Technology to an Existing Eye Care Professional Referral Program Increased the Rate of Surveillance and Treatment of Diabetic Retinopathy.
  437. Poor Pregnancy Outcome in Women With Type 2 Diabetes.

    23 January 2005

  438. Diabetes Care in the Veterans Affairs System and in Managed Care.
  439. Incomplete control of HbA1c levels is the major drawback to current non-insulin antidiabetics.

    16 January 2005

  440. Benefits of an insulin dosage calculation device for adolescents with type 1 diabetes mellitus.
  441. Parents' reflections on managing their children's diabetes with insulin pumps.
  442. The impact of diabetes mellitus and other chronic medical conditions on health-related quality of life: Is the whole greater than the sum of its parts? Free full text available in PDF format.
  443. Hyperglycemia and mortality references Persistent hyperglycemia in critically ill children.
  444. Hemolytic crisis in a non-ketotic and euglycemic child with glucose-6-phosphate dehydrogenase deficiency and onset of type 1 diabetes mellitus.
  445. Preventing foot ulcers in patients with diabetes.
  446. Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes; A prospective study of 1662 episodes.
  447. Glycemic index, postprandial glycemia and cardiovascular disease.
  448. Insulin resistance, low-fat diets, and low-carbohydrate diets: time to test new menus.
  449. Patient Safety and Medical System Errors in Diabetes and Endocrinology Consensus Conference: AACE Position Statement. See also Steps to prevent medical errors urged.

    9 January 2005

  450. Evaluation of an intensive treatment education program for type 1 diabetes in a group of adolescents. A two year follow up.
  451. Reduced severe hypoglycemia with insulin glargine in intensively treated adults with type 1 diabetes.
  452. The 12-month efficacy and safety of insulin detemir and NPH insulin in basal-bolus therapy for the treatment of type 1 diabetes.
  453. GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children.
  454. The Continuous Glucose Monitoring System during pregnancy of women with type 1 diabetes mellitus: accuracy assessment.
  455. Quality of life and diabetes knowledge of young persons with type 1 diabetes: Influence of treatment modalities and demographics.
  456. Annals of Medicine: The Pediatric Gap examines the challenges of giving children medications for which no formal dosing guidelines exist -- which is the case for 75% of FDA-approved drugs.
  457. FDA Eyes Food Label Carb Claims.
  458. Better systems, not guidelines, for glucose monitoring.
  459. Dietary supplement use is prevalent among children with a chronic illness.

    2 January 2005

  460. An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes.
  461. Drugstores Fret as Insurers Demand Pills by Mail highlights a growing problem for families -- insulin shipped by mail, resulting in potential spoilage due to temperature extremes.
  462. The Effect of Measured Carbohydrate Exchange Diets and Unmeasured Low Glycaemic Index Diets on Glycaemic Control in Children with Type 1 Diabetes.
  463. Dealing with self-management of chronic illness at work: predictors for self-disclosure.
  464. Hospital in-patients with diabetes: increasing prevalence and management problems.
  465. Vaccines for persons at high risk due to medical conditions, occupation, environment, or lifestyle, 2005.
  466. Clinical features of type 1 diabetic children at initial diagnosis.
  467. Recipe for Success (PDF) explores the challenges of pump care at a diabetes summer camp.
  468. Effecting Change: Development of a Pediatric Diabetes Case Managed Program.
  469. Effects of Hypoglycemia on Developmental Outcome in Children with Congenital Hyperinsulinism. See also Congenital Hyperinsulinism: Oh No! Too Low!
  470. Empowering Children and their Parents offers suggestions for parents whose children are afraid of injections.
  471. My Pump Holiday Was No Vacation.

[ Current Daily Care News | News from 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]

  Back to Current Daily Care News Return to the Top of This Page

Last Updated: Thursday January 01, 2015 15:28:56
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.